Societal CDMO, Inc., a contract development and manufacturing organization, engages in the research and development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecule therapeutic development in the United States and internationally. It provides therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market. The company was formerly known as Recro Pharma, Inc. and changed its name to Societal CDMO, Inc. in March 2022. Societal CDMO, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.
Earnings for Societal CDMO, Inc. (SCTL)
Earnings in 2023 (TTM): $-13,142,000
According to Societal CDMO, Inc.'s latest financial reports the company's current earnings (TTM) are $-13,142,000. The earnings displayed on this page is the company's Pretax Income.
Earnings history of Societal CDMO, Inc.
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $-13,142,000 | $-13,274,000 |
| 2022 | $-18,776,000 | $-19,881,000 |
| 2021 | $-11,370,000 | $-26,504,000 |
| 2020 | $-27,501,000 | $-46,660,000 |
| 2019 | $4.63 M | $-38,436,000 |
| 2018 | $-62,287,000 | $-79,723,000 |
| 2017 | $-51,960,000 | $-50,080,000 |
| 2016 | $-31,312,000 | $-30,205,000 |
| 2015 | $-12,518,000 | $3.03 M |
| 2014 | $-16,134,158 | $-16,134,158 |
| 2013 | $-1,957,818 | $-1,957,818 |
| 2012 | $-1,536,536 | $-1,536,536 |
| 2011 | $-2,870,918 | $-2,870,918 |